Trial Profile

Immunogenicity of the conjugate and polysaccharide pneumococcal vaccines in high-risk renal patients.

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccines
Indications Pneumococcal infections
Focus Pharmacodynamics
Sponsors Wyeth

Most Recent Events

13 Aug 2010 United Kingdom Clinical Research Network reports accrual to date as 150%; this was identified via CA tool.
13 Aug 2010 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
13 Aug 2010 Planned end date changed from 16 Apr 2008 to 18 Apr 2008 as reported by UKCRN.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com